Table 2.

Percent change in BCCs per year in subjects treated with placebo or celecoxib

No. subjectsPlacebo (95% CI)Celecoxib (95% CI)Pdifference
All subjects (BCC number)6037% (25-50)26% (17-36)0.18
    ≥15 BCCs at baseline 2428% (16-43)32% (18-48)0.74
    <15 BCCs at baseline3648% (27-71)22% (10-36)0.043
All subjects (BCC burden)6037% (24-50)25% (15-36)0.069
    ≥15 BCCs at baseline 2433% (19-48)33% (18-50)0.97
    <15 BCCs at baseline3650% (28-76)20% (6.8-35)0.024

Abbreviation: 95% CI, 95% confidence interval.